Toxicology Reports · 2015 · 63 citations · 89 references
PharmacyPharmacologyToxicologyBiochemical ToxicologyHepatotoxicologyMechanisms Of ToxicityChemical-induced HepatotoxicityCytotoxicity EvaluationGenotoxicity MechanismsHepatotoxicity MechanismsMolecular Mechanisms Of ToxicityNanotoxicologyAflatoxin HepatotoxicityAflatoxin-induced Liver InjuryChitosanChitosan TreatmentChitosan-based NanomaterialsNanoparticle-induced CytotoxicityNanoparticlesNitric Oxide
The aims of the current study were to prepare chitosan nanoparticles (CNPs) and to evaluate its protective role alone or in combination with quercetin (Q) against AFB1-induce cytotoxicity in rats. Male Sprague-Dawley rats were divided into 12 groups and treated orally for 4 weeks as follow: the control group, the group treated with AFB1 (80 μg/kg b.w.) in corn oil, the groups treated with low (140 mg/kg b.w.) or high (280 mg/kg b.w.) dose of CNPs, the group treated with Q (50 mg/kg b.w.), the groups treated with Q plus the low or the high dose of CNPs and the groups treated with AFB1 plus Q and/or CNPs at the two tested doses. The results also revealed that administration of AFB1 resulted in a significant increase in serum cytokines, Procollagen III, Nitric Oxide, lipid peroxidation and DNA fragmentation accompanied with a significant decrease in GPx I and Cu–Zn SOD-mRNA gene expression. Q and/or CNPs at the two tested doses overcome these effects especially in the group treated with the high dose of CNPs plus Q. It could be concluded that CNPs is a promise candidate as drug delivery enhances the protective effect of Q against the cytogenetic effects of AFB1 in high endemic areas.
89
Multiple Range Tests for Correlated and Heteroscedastic Means
David B. Duncan · Biometrics · 1957 · 958 citations